Holbrook Kohrt

Medical oncologist, Lymphoma specialist

Assistant Professor of Medicine (Oncology) at the Stanford University Medical Center

Lymphoma Program

  • 875 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-498-6000
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Residency: Stanford University Hospital -Clinical Excellence Research Center (2007) CA

Internship: Stanford University Hospital -Clinical Excellence Research Center (2006) CA

Fellowship: Stanford University - Hematology and Oncology (2011) CA

Board Certification: Internal Medicine, American Board of Internal Medicine (2008)

Medical Education: Stanford University School of Medicine (2005) CA

PhD, Stanford University, Clinical Trial Design & Tumor Immunology (2011)

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Depleting tumor-specific Tregs at a single site eradicates disseminated tumors.
Marabelle, A., Kohrt, H., Sagiv-Barfi, I., Ajami, B., Axtell, R. C., & Levy, R. (2013). Depleting tumor-specific Tregs at a single site eradicates disseminated tumors. journal of clinical investigation, 123(11), 4980-?.

Intratumoral anti-CTLA-4 therapy: enhancing efficacy while avoiding toxicity.
Marabelle, A., Kohrt, H., & Levy, R. (2013). Intratumoral anti-CTLA-4 therapy: enhancing efficacy while avoiding toxicity. Clinical cancer research , 19(19), 5261-5263.

Modulation of natural killer cell antitumor activity by the aryl hydrocarbon receptor
Shin, J. H., Zhang, L., Murillo-Sauca, O., Kim, J., Kohrt, H. Ek., & Sunwoo, J. B. (2013). Modulation of natural killer cell antitumor activity by the aryl hydrocarbon receptor. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 110(30), 12391-12396.

Identification of gene microarray expression profiles in patients with chronic graft-versus-host disease following allogeneic hematopoietic cell transplantation
Kohrt, H. E., Tian, L., Li, L., Alizadeh, A. A., Hsieh, S., & Lowsky, R. (2013). Identification of gene microarray expression profiles in patients with chronic graft-versus-host disease following allogeneic hematopoietic cell transplantation. CLINICAL IMMUNOLOGY, 148(1), 124-135.

Depleting tumor-specific Tregs at a single site eradicates disseminated tumors
Marabelle, A., Kohrt, H., Sagiv-Barfi, I., Ajami, B., Axtell, R. C., & Levy, R. (2013). Depleting tumor-specific Tregs at a single site eradicates disseminated tumors. JOURNAL OF CLINICAL INVESTIGATION, 123(6), 2447-2463.

High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells
Myklebust, J. H., Irish, J. M., Brody, J., Czerwinski, D. K., Houot, R., & Levy, R. (2013). High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells. BLOOD, 121(8), 1367-1376.

TLI-ATG Conditioning and Allogeneic Transplantation for Patients with MDS and MPN
Benjamin, J., Chhabra, S., Kohrt, H., Laport, G. G., Arai, S., & Lowsky, R. (2013). TLI-ATG Conditioning and Allogeneic Transplantation for Patients with MDS and MPN. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 19(2), S113-S114.

Outcomes After Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation with Total Lymphoid Irradiation and Anti-Thymocyte Globulin in Lymphoid Malignancies After Failed Autologous Transplantation
Kanate, A. S., Efron, B., Chhabra, S., Kohrt, H., Shizuru, J. A., & Lowsky, R. (2013). Outcomes After Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation with Total Lymphoid Irradiation and Anti-Thymocyte Globulin in Lymphoid Malignancies After Failed Autologous Transplantation. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 19(2), S154-S155.

Cancer Vaccines and T Cell Therapy
Rezvani, K., Brody, J. D., Kohrt, H. E., Logan, A. C., Advani, R., & Barrett, J. (2013). Cancer Vaccines and T Cell Therapy. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 19(1), S97-S101.

Breast Cancer Treatment with Imiquimod: Applying an Old Lotion to a New Disease
Kohrt, H. (2012). Breast Cancer Treatment with Imiquimod: Applying an Old Lotion to a New Disease. CLINICAL CANCER RESEARCH, 18(24), 6571-6573.

Immune Injury by Allogeneic CD4(+) T Cells Leads to Host Hematopoietic Stem Cell Dormancy and Prevents Engraftment of Donor Cells
Mueller, A. Ms., Florek, M., Kohrt, H. E., & Shizuru, J. A. (2012). Immune Injury by Allogeneic CD4(+) T Cells Leads to Host Hematopoietic Stem Cell Dormancy and Prevents Engraftment of Donor Cells. BLOOD, 120(21).

Targeting B-Cell Lymphoma with Idiotype-Specific Peptibodies: Toward a Personalized and Tumor-Specific Therapy
Torchia, J. A., Ng, P. P., Chen, H., Kohrt, H. E., Marabelle, A., & Levy, R. (2012). Targeting B-Cell Lymphoma with Idiotype-Specific Peptibodies: Toward a Personalized and Tumor-Specific Therapy. BLOOD, 120(21).

Achieving Selective Graft-Versus-Leukemia without Graft-Versus-Host Effects by WT1 Peptide Vaccination of Donors and Stringent Engineering of the Allo-Graft
Mueller, A. Ms., Shizuru, J. A., & Kohrt, H. E. (2012). Achieving Selective Graft-Versus-Leukemia without Graft-Versus-Host Effects by WT1 Peptide Vaccination of Donors and Stringent Engineering of the Allo-Graft. BLOOD, 120(21).

in Situ Vaccination for Patients with Previously Untreated Follicular Lymphoma: Analysis of Immune Responses
Czerwinski, D. K., Brody, J., Kohrt, H. E., Hoppe, R. T., Advani, R. H., & Levy, R. (2012). in Situ Vaccination for Patients with Previously Untreated Follicular Lymphoma: Analysis of Immune Responses. BLOOD, 120(21).

Identification of Candidate Transcriptional Biomarkers Associated with Chronic Graft-Versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation
Kohrt, H. E., Tian, L., Li, L., Alizadeh, A. A., Hsieh, S., & Lowsky, R. (2012). Identification of Candidate Transcriptional Biomarkers Associated with Chronic Graft-Versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation. BLOOD, 120(21).

Non-Myeloablative Conditioning with Total Lymphoid Irradiation and ATG and Allogeneic Transplantation for Patients with Myelodysplastic Syndrome, Therapy-Related Myeloid Neoplasms, and Myeloproliferative Neoplasms.
Benjamin, J., Chhabra, S., Kohrt, H. E., Laport, G. G., Arai, S., & Lowsky, R. (2012). Non-Myeloablative Conditioning with Total Lymphoid Irradiation and ATG and Allogeneic Transplantation for Patients with Myelodysplastic Syndrome, Therapy-Related Myeloid Neoplasms, and Myeloproliferative Neoplasms. BLOOD, 120(21).

Intratumoral Treg immunomodulation at a single site cures disseminated disease including in the brain
Marabelle, A., Kohrt, H., Brody, J., Torchia, J., Rajapaksa, R., & Levy, R. (2012). Intratumoral Treg immunomodulation at a single site cures disseminated disease including in the brain. BRITISH JOURNAL OF HAEMATOLOGY, 159, 12-12.

Immune injury by allogeneic CD4(+) T cells leads to host hematopoietic stem cell dormancy and prevents engraftment of donor cells
Mueller, A. Ms., Florek, M., Kohrt, H., & Shizuru, J. A. (2012). Immune injury by allogeneic CD4(+) T cells leads to host hematopoietic stem cell dormancy and prevents engraftment of donor cells. ONKOLOGIE, 35, 102-102.

CD137 Is Expressed in Follicular Dendritic Cell Tumors and in Classical Hodgkin and T-Cell Lymphomas Diagnostic and Therapeutic Implications
Anderson, M. W., Zhao, S., Freud, A. G., Czerwinski, D. K., Kohrt, H., & Natkunam, Y. (2012). CD137 Is Expressed in Follicular Dendritic Cell Tumors and in Classical Hodgkin and T-Cell Lymphomas Diagnostic and Therapeutic Implications. AMERICAN JOURNAL OF PATHOLOGY, 181(3), 795-803.

The chemoattractant chemerin suppresses melanoma by recruiting natural killer cell antitumor defenses
Pachynski, R. K., Zabel, B. A., Kohrt, H. E., Tejeda, N. M., Monnier, J., & Butcher, E. C. (2012). The chemoattractant chemerin suppresses melanoma by recruiting natural killer cell antitumor defenses. JOURNAL OF EXPERIMENTAL MEDICINE, 209(8), 1427-1435.

Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells
Gill, S., Vasey, A. E., De Souza, A., Baker, J., Smith, A. T., & Negrin, R. S. (2012). Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells. BLOOD, 119(24), 5758-5768.

Effect of stimulation of natural killer cells with an anti-CD137 mAb on the efficacy of trastuzumab, cetuximab, and rituximab
Kohrt, H. E., Houot, R., Weiskopf, K., Goldstein, M., Lund, P., & Levy, R. (2012). Effect of stimulation of natural killer cells with an anti-CD137 mAb on the efficacy of trastuzumab, cetuximab, and rituximab. JOURNAL OF CLINICAL ONCOLOGY, 30(15).

The chemoattractant chemerin as a natural tumor suppressive cytokine.
Pachynski, R. K., Zabel, B., Tejeda, N., Monnier, J., Holzer, A. K., & Butcher, E. (2012). The chemoattractant chemerin as a natural tumor suppressive cytokine. JOURNAL OF CLINICAL ONCOLOGY, 30(15).

Combination strategies to enhance antitumor ADCC
Kohrt, H. E., Houot, R., Marabelle, A., Cho, H. J., Osman, K., & Brody, J. (2012). Combination strategies to enhance antitumor ADCC. IMMUNOTHERAPY, 4(5), 511-527.

Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide for elderly patients with acute myeloid leukemia
Pollyea, D. A., Kohrt, H. E., Gallegos, L., Figueroa, M. E., Abdel-Wahab, O., & Medeiros, B. C. (2012). Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide for elderly patients with acute myeloid leukemia. LEUKEMIA, 26(5), 893-901.

Reduced intensity conditioning is superior to nonmyeloablative conditioning for older chronic myelogenous leukemia patients undergoing hematopoietic cell transplant during the tyrosine kinase inhibitor era
Warlick, E., Ahn, K. W., Pedersen, T. L., Artz, A., de Lima, M., & Weisdorf, D. (2012). Reduced intensity conditioning is superior to nonmyeloablative conditioning for older chronic myelogenous leukemia patients undergoing hematopoietic cell transplant during the tyrosine kinase inhibitor era. BLOOD, 119(17), 4083-4090.

Co-transplantation of pure blood stem cells with antigen-specific but not bulk T cells augments functional immunity
Mueller, A. Ms., Shashidhar, S., Kuepper, N. J., Kohrt, H. Ek., Florek, M., & Shizuru, J. A. (2012). Co-transplantation of pure blood stem cells with antigen-specific but not bulk T cells augments functional immunity. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 109(15), 5820-5825.

Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer
Kohrt, H. E., Houot, R., Weiskopf, K., Goldstein, M. J., Scheeren, F., & Levy, R. (2012). Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer. JOURNAL OF CLINICAL INVESTIGATION, 122(3), 1066-1075.

Adoptive Cell Therapy for Lymphoma with CD4 T Cells Depleted of CD137-Expressing Regulatory T Cells
Goldstein, M. J., Kohrt, H. E., Houot, R., Varghese, B., Lin, J. T., & Levy, R. (2012). Adoptive Cell Therapy for Lymphoma with CD4 T Cells Depleted of CD137-Expressing Regulatory T Cells. CANCER RESEARCH, 72(5), 1239-1247.

SPACE AND TOLERANCE ARE CRITICAL FOR ENGRAFTMENT OF HEMATOPOIETIC ALLOGRAFTS IN RECIPIENTS CONDITIONED WITH TOTAL LYMPHOID IRRADIATION PLUS ATG
Mueller, A. Ms., Poyser, J., Kuepper, N. J., Burnett, C., Kohrt, H. Ek., & Shizuru, J. A. (2012). SPACE AND TOLERANCE ARE CRITICAL FOR ENGRAFTMENT OF HEMATOPOIETIC ALLOGRAFTS IN RECIPIENTS CONDITIONED WITH TOTAL LYMPHOID IRRADIATION PLUS ATG. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 18(2), S326-S327.

What Happened to the Concept of the Physician-Scientist?
Goldstein, M. J., & Kohrt, H. E. (2012). What Happened to the Concept of the Physician-Scientist?. ACADEMIC MEDICINE, 87(2), 132-133.

Long-Term Outcome of Patients with Metastatic Breast Cancer Treated with High-Dose Chemotherapy and Transplantation of Purified Autologous Hematopoietic Stem Cells
Mueller, A. Ms., Kohrt, H. Ek., Cha, S., Laport, G., Klein, J., & Shizuru, J. A. (2012). Long-Term Outcome of Patients with Metastatic Breast Cancer Treated with High-Dose Chemotherapy and Transplantation of Purified Autologous Hematopoietic Stem Cells. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 18(1), 125-133.

Tailored temozolomide therapy according to MGMT methylation status for elderly patients with acute myeloid leukemia
Medeiros, B. C., Kohrt, H. E., Gotlib, J., Coutre, S. E., Zhang, B., & Zehnder, J. L. (2012). Tailored temozolomide therapy according to MGMT methylation status for elderly patients with acute myeloid leukemia. AMERICAN JOURNAL OF HEMATOLOGY, 87(1), 45-50.

Treatment advances have not improved the early death rate in acute promyelocytic leukemia
McClellan, J. S., Kohrt, H. E., Coutre, S., Gotlib, J. R., Majeti, R., & Medeiros, B. C. (2012). Treatment advances have not improved the early death rate in acute promyelocytic leukemia. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 97(1), 133-136.

Immunotransplant for Mantle Cell Lymphoma: Phase I/II Study Preliminary Results
Brody, J. D., Czerwinski, D. K., Carlton, V., Moorhead, M., Zheng, J., & Levy, R. (2011). Immunotransplant for Mantle Cell Lymphoma: Phase I/II Study Preliminary Results. BLOOD, 118(21), 1323-1323.

Donor Immunization with WT1 Peptide Augments Anti-Leukemic Activity After MHC-Matched Bone Marrow Transplantation
Kohrt, H. E., Mueller, A. Ms., Baker, J. B., Goldstein, M. J., Newell, E., & Strober, S. (2011). Donor Immunization with WT1 Peptide Augments Anti-Leukemic Activity After MHC-Matched Bone Marrow Transplantation. BLOOD, 118(21), 827-828.

Natural Killer Cell Adoptive Immunotherapy Is Hampered by A Rapid Development of NK Cell Dysfunction Characterized by Loss of Effector Mechanisms and Downregulation of the Transcription Factors T-Bet and Eomesodermin; Definition and Possible Mechanism of NK Cell Exhaustion
Gill, S. I., Vasey, A. E., Baker, J. B., Smith, A., Kohrt, H. E., & Negrin, R. S. (2011). Natural Killer Cell Adoptive Immunotherapy Is Hampered by A Rapid Development of NK Cell Dysfunction Characterized by Loss of Effector Mechanisms and Downregulation of the Transcription Factors T-Bet and Eomesodermin; Definition and Possible Mechanism of NK Cell Exhaustion. BLOOD, 118(21), 457-457.

Graft T Cells Retard Stem Cell Derived Lymphoid Organ Reconstitution and Immune Function After Allogeneic Transplantation
Mueller, A. Ms., Kohrt, H. E., Shashidhar, S., Florek, M., Kuepper, N. J., & Shizuru, J. A. (2011). Graft T Cells Retard Stem Cell Derived Lymphoid Organ Reconstitution and Immune Function After Allogeneic Transplantation. BLOOD, 118(21), 1722-1722.

Donor immunization with WT1 peptide augments antileukemic activity after MHC-matched bone marrow transplantation.
Kohrt, H. E., Müller, A., Baker, J., Goldstein, M. J., Newell, E., & Strober, S. (2011). Donor immunization with WT1 peptide augments antileukemic activity after MHC-matched bone marrow transplantation. Blood, 118(19), 5319-5329.

SYSTEMIC ANTITUMOR IMMUNITY TRIGGERED BY INTRATUMORAL IMMUNOMODULATION CURES DISTANT METASTATIC CNS LYMPHOMA
Marabelle, A., Kohrt, H., Brody, J., Luong, R., Tse, V., & Levy, R. (2011). SYSTEMIC ANTITUMOR IMMUNITY TRIGGERED BY INTRATUMORAL IMMUNOMODULATION CURES DISTANT METASTATIC CNS LYMPHOMA. NEURO-ONCOLOGY, 13, 38-38.

Targeting immune effector cells to promote antibody-induced cytotoxicity in cancer immunotherapy
Houot, R., Kohrt, H. E., Marabelle, A., & Levy, R. (2011). Targeting immune effector cells to promote antibody-induced cytotoxicity in cancer immunotherapy. TRENDS IN IMMUNOLOGY, 32(11), 510-516.

Selective Resistance of CD44(hi) T Cells to p53-Dependent Cell Death Results in Persistence of Immunologic Memory after Total Body Irradiation
Yao, Z., Jones, J., Kohrt, H., & Strober, S. (2011). Selective Resistance of CD44(hi) T Cells to p53-Dependent Cell Death Results in Persistence of Immunologic Memory after Total Body Irradiation. JOURNAL OF IMMUNOLOGY, 187(8), 4100-4108.

Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment
Alizadeh, A. A., Gentles, A. J., Alencar, A. J., Liu, C. L., Kohrt, H. E., & Levy, R. (2011). Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment. BLOOD, 118(5), 1350-1358.

Cytotoxic T lymphocyte responses against melanocytes and melanoma
Chang, G. Y., Kohrt, H. E., Stuge, T. B., Schwartz, E. J., Weber, J. S., & Lee, P. P. (2011). Cytotoxic T lymphocyte responses against melanocytes and melanoma. JOURNAL OF TRANSLATIONAL MEDICINE, 9.

Prolonged disease-free survival and overall survival with CVP alternating with fludarabine in advanced follicular lymphoma
Ai, W. Z., Kohrt, H. Ek., Timmerman, J., Hwang, J., Hsu, F. J., & Levy, R. (2011). Prolonged disease-free survival and overall survival with CVP alternating with fludarabine in advanced follicular lymphoma. AMERICAN JOURNAL OF HEMATOLOGY, 86(6), 515-518.

Active and Passive Immunotherapy for Lymphoma: Proving Principles and Improving Results
Brody, J., Kohrt, H., Marabelle, A., & Levy, R. (2011). Active and Passive Immunotherapy for Lymphoma: Proving Principles and Improving Results. JOURNAL OF CLINICAL ONCOLOGY, 29(14), 1864-1875.

CD8(+)CD44(hi) but not CD4(+)CD44(hi) memory T cells mediate potent graft antilymphoma activity without GVHD
Dutt, S., Baker, J., Kohrt, H. E., Kambham, N., Sanyal, M., & Strober, S. (2011). CD8(+)CD44(hi) but not CD4(+)CD44(hi) memory T cells mediate potent graft antilymphoma activity without GVHD. BLOOD, 117(11), 3230-3239.

Immunomodulating antibodies and drugs for the treatment of hematological malignancies
Houot, R., Kohrt, H., Goldstein, M. J., & Levy, R. (2011). Immunomodulating antibodies and drugs for the treatment of hematological malignancies. CANCER AND METASTASIS REVIEWS, 30(1), 97-109.

Acute myeloid leukaemia in the elderly: a review
Pollyea, D. A., Kohrt, H. E., & Medeiros, B. C. (2011). Acute myeloid leukaemia in the elderly: a review. BRITISH JOURNAL OF HAEMATOLOGY, 152(5), 524-542.

CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies
Kohrt, H. E., Houot, R., Goldstein, M. J., Weiskopf, K., Alizadeh, A. A., & Levy, R. (2011). CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies. BLOOD, 117(8), 2423-2432.

LONG-TERM FOLLOW-UP OF METASTATIC BREAST CANCER PATIENTS RECEIVING HIGHLY PURIFIED AUTOLOGOUS CD34+THY-1+HEMATOPOIETIC STEM CELLS AFTER HIGH-DOSE CHEMOTHERAPY
Mueller, A. Ms., Kohrt, H. Ek., Laport, G. G., Negrin, R. S., Cha, S., & Shizuru, J. A. (2011). LONG-TERM FOLLOW-UP OF METASTATIC BREAST CANCER PATIENTS RECEIVING HIGHLY PURIFIED AUTOLOGOUS CD34+THY-1+HEMATOPOIETIC STEM CELLS AFTER HIGH-DOSE CHEMOTHERAPY. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 17(2), S198-S198.

A CpG-loaded tumor cell vaccine induces antitumor CD4(+) T cells that are effective in adoptive therapy for large and established tumors
Goldstein, M. J., Varghese, B., Brody, J. D., Rajapaksa, R., Kohrt, H., & Levy, R. (2011). A CpG-loaded tumor cell vaccine induces antitumor CD4(+) T cells that are effective in adoptive therapy for large and established tumors. BLOOD, 117(1), 118-127.

Noninvasive Prediction of Graft-Verus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation by Gene Expression Profiling
Kohrt, H. E., Li, L., Alizadeh, A. A., Goldstein, M. J., Strober, S., & Lowsky, R. (2010). Noninvasive Prediction of Graft-Verus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation by Gene Expression Profiling. BLOOD, 116(21), 393-394.

Temozolomide In Acute Myeloid Leukemia: A MGMT Promoter Methylation Status-Based Treatment Stratification
Medeiros, B. C., Kohrt, H. E., Rajwanshi, R., Gotlib, J., Coutre, S., & Zehnder, J. L. (2010). Temozolomide In Acute Myeloid Leukemia: A MGMT Promoter Methylation Status-Based Treatment Stratification. BLOOD, 116(21), 1357-1358.

Immunomodulation of NK Cells through 4-1BB (CD137) to Improve the Anti-Lymphoma Activity of Rituximab: Antibody-Based Anti-Lymphoma
Kohrt, H. E., Houot, R., Goldstein, M. J., Weiskopf, K., Chao, M., & Levy, R. (2010). Immunomodulation of NK Cells through 4-1BB (CD137) to Improve the Anti-Lymphoma Activity of Rituximab: Antibody-Based Anti-Lymphoma. BLOOD, 116(21), 188-189.

Clinical and Pathological Features of Non-Hodgkin Lymphomas Harboring Concurrent t(14;18) and 8q24 Anomalies
Alizadeh, A. A., Anderson, M., Kohrt, H. E., Shyam, R. M., Bangs, C. D., & Levy, R. (2010). Clinical and Pathological Features of Non-Hodgkin Lymphomas Harboring Concurrent t(14;18) and 8q24 Anomalies. BLOOD, 116(21), 1291-1292.

Prediction of Survival In Diffuse Large B-Cell Lymphoma Based On the Expression of Two Genes Reflecting Tumor and Microenvironment
Alizadeh, A. A., Gentles, A. J., Alencar, A. J., Kohrt, H. E., Houot, R., & Levy, R. (2010). Prediction of Survival In Diffuse Large B-Cell Lymphoma Based On the Expression of Two Genes Reflecting Tumor and Microenvironment. BLOOD, 116(21), 836-837.

A Phase I Study of Sequential Azacitidine and Lenalidomide for Elderly Patients with Acute Myeloid Leukemia (AML)
Pollyea, D. A., Kohrt, H. E., Gallegos, L., Berube, C., Coutre, S., & Medeiros, B. C. (2010). A Phase I Study of Sequential Azacitidine and Lenalidomide for Elderly Patients with Acute Myeloid Leukemia (AML). BLOOD, 116(21), 1347-1347.

CD137 Identifies a Population of Regulatory T Cells That Inhibit Anti-Tumor Immune Responses In Adoptive Immunotherapy
Goldstein, M. J., Kohrt, H. E., Houot, R., Varghese, B., Lin, J. T., & Levy, R. (2010). CD137 Identifies a Population of Regulatory T Cells That Inhibit Anti-Tumor Immune Responses In Adoptive Immunotherapy. BLOOD, 116(21), 868-868.

NF-kappa B Signaling In Response to CpG Stratifies Mantle Cell Lymphoma Patient Outcome
Myklebust, J. H., Irish, J. M., Brody, J., Alizadeh, A. A., Czerwinski, D., & Levy, R. (2010). NF-kappa B Signaling In Response to CpG Stratifies Mantle Cell Lymphoma Patient Outcome. BLOOD, 116(21), 67-68.

Second-line mitoxantrone, etoposide, and cytarabine for acute myeloid leukemia: A single-center experience
Kohrt, H. E., Patel, S., Ho, M., Owen, T., Pollyea, D. A., & Medeiros, B. C. (2010). Second-line mitoxantrone, etoposide, and cytarabine for acute myeloid leukemia: A single-center experience. AMERICAN JOURNAL OF HEMATOLOGY, 85(11), 877-881.

Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma
Chao, M. P., Alizadeh, A. A., Tang, C., Myklebust, J. H., Varghese, B., & Majeti, R. (2010). Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma. CELL, 142(5), 699-713.

Risk stratification in extranodal natural killer/T-cell lymphoma
Kohrt, H., Lee, M., & Advani, R. (2010). Risk stratification in extranodal natural killer/T-cell lymphoma. EXPERT REVIEW OF ANTICANCER THERAPY, 10(9), 1395-1405.

Quantitative, Architectural Analysis of Immune Cell Subsets in Tumor-Draining Lymph Nodes from Breast Cancer Patients and Healthy Lymph Nodes
Setiadi, A. F., Ray, N. C., Kohrt, H. E., Kapelner, A., Carcamo-Cavazos, V., & Lee, P. P. (2010). Quantitative, Architectural Analysis of Immune Cell Subsets in Tumor-Draining Lymph Nodes from Breast Cancer Patients and Healthy Lymph Nodes. PLOS ONE, 5(8).

NKT cells, Treg, and their interactions in bone marrow transplantation
Kohrt, H. E., Pillai, A. B., Lowsky, R., & Strober, S. (2010). NKT cells, Treg, and their interactions in bone marrow transplantation. EUROPEAN JOURNAL OF IMMUNOLOGY, 40(7), 1862-1869.

Immunophenotypic features of acute myeloid leukemia with inv(3)(q21q26.2)/t(3;3)(q21;q26.2)
Medeiros, B. C., Kohrt, H. E., Arber, D. A., Bangs, C. D., Cherry, A. M., & Alizadeh, A. A. (2010). Immunophenotypic features of acute myeloid leukemia with inv(3)(q21q26.2)/t(3;3)(q21;q26.2). LEUKEMIA RESEARCH, 34(5), 594-597.

Noninvasive Prediction of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation by Gene Expression Profiling.
Li, L., Kohrt, H., Heish, S., Alizadeh, A., Laport, G., & Sarwal, M. (2010). Noninvasive Prediction of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation by Gene Expression Profiling. AMERICAN JOURNAL OF TRANSPLANTATION, 10, 483-483.

Is Time of the Essence in Adult Acute Myeloid Leukemia (AML)? Time to Blast Clearance and Time to Induction Therapy Fail to Predict Overall Survival (OS).
Kohrt, H. E., Patel, S., Ho, M., Owen, T., Majeti, R., & Alizadeh, A. A. (2009). Is Time of the Essence in Adult Acute Myeloid Leukemia (AML)? Time to Blast Clearance and Time to Induction Therapy Fail to Predict Overall Survival (OS). BLOOD, 114(22), 646-647.

Prediction of Survival in Diffuse Large B-Cell Lymphoma Based On the Expression of Two Genes: Integration of Tumor and Microenvironment Contributions
Alizadeh, A. A., Gentles, A. J., Alencar, A. J., Kohrt, H. E., Houot, R., & Levy, R. (2009). Prediction of Survival in Diffuse Large B-Cell Lymphoma Based On the Expression of Two Genes: Integration of Tumor and Microenvironment Contributions. BLOOD, 114(22), 258-258.

Adoptive Therapy for Lymphoma with CD4 Memory T Cells Depleted of CD137-Expressing Tregs.
Goldstein, M. J., Houot, R., Kohrt, H. E., Brody, J., & Levy, R. (2009). Adoptive Therapy for Lymphoma with CD4 Memory T Cells Depleted of CD137-Expressing Tregs. BLOOD, 114(22), 674-675.

Early Mortality in Acute Promyelocytic Leukemia May Be Higher Than Previously Reported.
Alizadeh, A. A., McClellan, J. S., Gotlib, J. R., Coutre, S., Majeti, R., & Medeiros, B. C. (2009). Early Mortality in Acute Promyelocytic Leukemia May Be Higher Than Previously Reported. BLOOD, 114(22), 420-421.

Therapeutic Potential of Anti-CD137 Antibody in Lymphoma
Houot, R., Goldstein, M. J., Kohrt, H. E., Myklebust, J. H., Alizadeh, A. A., & Levy, R. (2009). Therapeutic Potential of Anti-CD137 Antibody in Lymphoma. BLOOD, 114(22), 301-302.

Nonmyeloablative conditioning with total lymphoid irradiation and antithymocyte globulin: an update
Kohrt, H., & Lowsky, R. (2009). Nonmyeloablative conditioning with total lymphoid irradiation and antithymocyte globulin: an update. CURRENT OPINION IN HEMATOLOGY, 16(6), 460-465.

Therapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by T-reg depletion
Houot, R., Goldstein, M. J., Kohrt, H. E., Myklebust, J. H., Alizadeh, A. A., & Levy, R. (2009). Therapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by T-reg depletion. BLOOD, 114(16), 3431-3438.

TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors
Kohrt, H. E., Turnbull, B. B., Heydari, K., Shizuru, J. A., Laport, G. G., & Lowsky, R. (2009). TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors. BLOOD, 114(5), 1099-1109.

Total lymphoid irradiation for graft-versus-host disease protection.
Kohrt, H., & Lowsky, R. (2009). Total lymphoid irradiation for graft-versus-host disease protection. Current opinion in oncology, 21, S23-6.

Dynamic CD8 T-cell responses to tumor-associated Epstein-Barr virus (EBV) antigens in patients with EBV-negative Hodgkin's disease
Kohrt, H. E., Advani, R., Hoppe, R., Rosenberg, S., Horning, S., & Lee, P. P. (2009). Dynamic CD8 T-cell responses to tumor-associated Epstein-Barr virus (EBV) antigens in patients with EBV-negative Hodgkin's disease. JOURNAL OF CLINICAL ONCOLOGY, 27(15).

Extranodal natural killer/T-cell lymphoma: current concepts in biology and treatment
Kohrt, H., & Advani, R. (2009). Extranodal natural killer/T-cell lymphoma: current concepts in biology and treatment. LEUKEMIA & LYMPHOMA, 50(11), 1773-1784.

Dynamic CD8 T-Cell Responses to Tumor-Associated Epstein-Barr Virus Antigens in Patients With Epstein-Barr Virus-Negative Hodgkin's Disease
Kohrt, H., Johannsen, A., Hoppe, R., Horning, S. J., Rosenberg, S. A., & Lee, P. P. (2009). Dynamic CD8 T-Cell Responses to Tumor-Associated Epstein-Barr Virus Antigens in Patients With Epstein-Barr Virus-Negative Hodgkin's Disease. ONCOLOGY RESEARCH, 18(5-6), 287-292.

Outcomes Following Allogeneic Hematopoietic Cell Transplantation (HCT) Using Non-Myeloablative Conditioning with Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) Confirm a Low Incidence of Graft Versus Host Disease (GVHD) with Retained Anti-Tumor Activity.
Kohrt, H., Turnbull, B., Laport, G., Miklos, D., Shizuru, J., & Lowsky, R. (2008). Outcomes Following Allogeneic Hematopoietic Cell Transplantation (HCT) Using Non-Myeloablative Conditioning with Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) Confirm a Low Incidence of Graft Versus Host Disease (GVHD) with Retained Anti-Tumor Activity. BLOOD, 112(11), 1136-1137.

Optimizing therapy for acute myeloid leukemia.
Kohrt, H. E., & Coutre, S. E. (2008). Optimizing therapy for acute myeloid leukemia. Journal of the National Comprehensive Cancer Network , 6(10), 1003-1016.

Renal failure and rhabdomyolysis associated with sitagliptin and simvastatin use
Kao, D. P., Kohrt, H. E., & Kugler, J. (2008). Renal failure and rhabdomyolysis associated with sitagliptin and simvastatin use. DIABETIC MEDICINE, 25(10), 1229-1230.

New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients
Kohrt, H., Olshen, R., Bermas, H., GOODSON, W., Henry, S., & JEFFREY, S. (2008). New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients. BREAST CANCER RESEARCH AND TREATMENT, 109(3), 588-588.

New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients
Kohrt, H. E., Olshen, R. A., Bermas, H. R., Goodson, W. H., Wood, D. J., & Jeffrey, S. S. (2008). New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients. BMC CANCER, 8.

Massive splenic infarct in a collegiate football player with hemoglobin SC disease
Ouyang, D. L., Kohrt, H. E., Garza, D., & Matheson, G. O. (2008). Massive splenic infarct in a collegiate football player with hemoglobin SC disease. CLINICAL JOURNAL OF SPORT MEDICINE, 18(1), 89-91.

Antiviral prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection.
Kohrt, H. E., Ouyang, D. L., & Keeffe, E. B. (2007). Antiviral prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection. Clinics in liver disease, 11(4), 965-?.

Systematic review: lamivudine prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection
Kohrt, H. E., Ouyang, D. L., & Keeffe, E. B. (2006). Systematic review: lamivudine prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 24(7), 1003-1016.

Predicting non-sentinel lymph node involvement in breast cancer patients.
Kohrt, H. E., Olshen, R. A., Goodson, W. H., Rouse, R. V., Bailey, L., & Jeffrey, S. S. (2006). Predicting non-sentinel lymph node involvement in breast cancer patients. JOURNAL OF CLINICAL ONCOLOGY, 24(18), 10S-10S.

Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer
Kohrt, H. E., Nouri, N., Nowels, K., Johnson, D., Holmes, S., & Lee, P. P. (2005). Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer. PLOS MEDICINE, 2(9), 904-919.

Rapid assessment of recognition efficiency and functional capacity of antigen-specific T-cell responses
Kohrt, H. E., Shu, C. T., Stuge, T. B., Holmes, S. P., Weber, J., & Lee, P. P. (2005). Rapid assessment of recognition efficiency and functional capacity of antigen-specific T-cell responses. JOURNAL OF IMMUNOTHERAPY, 28(4), 297-305.

Distribution of distress in post-socialist Mongolia: a cultural epidemiology of yadargaa
Kohrt, B. A., Hruschka, D. J., Kohrt, H. E., Panebianco, N. L., & Tsagaankhuu, G. (2004). Distribution of distress in post-socialist Mongolia: a cultural epidemiology of yadargaa. SOCIAL SCIENCE & MEDICINE, 58(3), 471-485.

An ecological-transactional model of significant risk factors for child psychopathology in outer Mongolia
Kohrt, H. E., Kohrt, B. A., Waldman, I., Saltzman, K., & Carrion, V. G. (2004). An ecological-transactional model of significant risk factors for child psychopathology in outer Mongolia. CHILD PSYCHIATRY & HUMAN DEVELOPMENT, 35(2), 163-181.